Enzyme-Linked Immunosorbent Assay (ELISA) is a test performed to detect the presence of antibodies in a biological liquid sample.  ELISA is used as quality control check in many industry and as a diagnostic tool in plant pathology and in medicine. 
 
Though the latest emerging technology i.e. themultiplex proteomic array platform is rapidly replacing the ELISA, its market continues to grow since it is being preferred as a secondary validation tool to confirm the results of multiplex proteomic platform. Emergence of cost effective technologies and laboratory automation are some of the major factorsthat are driving the global ELISA market towards growth. The existing ELISA manufacturers are currently facing price pressures due to increase in the number of market players, thereby increasing competitive rivalry. In order to survive the market competition, many market players are have begun to shift their focus on niche marketsand have increased their efforts in developing innovative solutions. 
 
The ELISA market can be segmented based on test types such as:
  • Sandwich ELISA
  • Indirect ELISA
  • Multiple and portable ELISA
  • Competitive ELISA
This market is further segmented on the basis of applications, such as:
  • Immunology
  • Inflammation
  • Infectious diseases
  • Cancer
  • Protein quantitation
  • Other
Geographically, the global enzyme-linked immunosorbent assay market can be categorized into North America, Europe, Asia-Pacific and rest of the world regions. North America,particularly the United States currently leads this marketand is followed by Europe due to widespread existence and early adoption of highly developed technologies and supportive economy. Asia-Pacific is a promising market for ELISA kits and is expected to undergo rapid market growth. Especially countries like China and India are promising regions, reason being rapidly growing medical tourism industry in India and China will increase the use of ELISA test as a diagnostic tool.  
 
Some of the market players leading the enzyme-linked immunosorbent assay (ELISA) market include Ortho-Clinical Diagnostics, Inc., Thermo Fisher Scientific. Inc., Life Technologies Corporation and ZEUS Scientific, Inc.

Disclaimer: This ongoing market research study is a meticulously planned activity where a broad array of factors and aspects that shape the marketing environment and industry are taken into account. However, keeping in mind the constantly changing nature of business dynamics and changing strategic intents, we are always actively making iterations and modifications in our approaches. As always, we are ready to tailor our insights and guidance to suit your requirements. Engage with us to know what more is there for your CXOs.

Enquiry Before Buying

TMR offers Enquiry Before Buying that help clients to get information on their business scenario required where syndicated solutions are not enough.

Enquiry Before Buying

Enzyme-Linked Immunosorbent Assay (ELISA) Technologies Market